Therapeutic ineffectiveness: Heads or tails?

Albert Figueras, Consuelo Pedrós, Mabel Valsecia, Joan Ramon Laporte

Research output: Contribution to journalReview articleResearchpeer-review

18 Citations (Scopus)

Abstract

Reporting of therapeutic ineffectiveness through adverse drug reaction spontaneous reporting systems has been proposed by some authors. In the WHO Adverse Reactions Terminology (WHO-ART) and Medical Dictionary for Regulatory Activities (MedDRA) terminology, the term therapeutic ineffectiveness includes drug interactions, resistance, tolerance and tachyphylaxis, as well as pharmaceutical defects such as substandard, adulterated, and counterfeit drugs. Under certain circumstances, reporting therapeutic ineffectiveness may contribute to identifying pharmaceutical defects. However, the best approach to avoid their occurrence would be implementing good manufacturing practices and strengthening quality control activities. This would prevent the misuse of spontaneous reporting of adverse drug reactions (e.g. when reporting of therapeutic ineffectiveness is 'suggested' by interested parties, especially when a generic product has been substituted for a branded original product).
Original languageEnglish
Pages (from-to)485-487
JournalDrug Safety
Volume25
Issue number7
DOIs
Publication statusPublished - 1 Jan 2002

Fingerprint Dive into the research topics of 'Therapeutic ineffectiveness: Heads or tails?'. Together they form a unique fingerprint.

Cite this